200 likes | 331 Views
Current status and future prospective s of technology transfer at the Croatian Ruđer Bošković Institute. Danica Ramljak, D.V.M., Ph.D. Institute today. 20 000 2 area. IRB OVERVIEW BY BRANCHES. TOTAL = 867 EMPLOYEES 542 RESEARCH STAFF (344 WITH PhD) +
E N D
Current status and future prospectives of technology transfer at the Croatian Ruđer Bošković Institute Danica Ramljak, D.V.M., Ph.D.
Institute today 20 000 2 area
TOTAL = 867 EMPLOYEES 542 RESEARCH STAFF (344 WITH PhD) + 325 SUPPORT AND TECHNICAL STAFF > 200 znanstvenih novaka • 198 YOUNG RESEARCHERS • 34 YOUNG RESEARCHERS WITH PhD • 118 SENIOR RESEARCH ASSOCIATES • RESEARCH ASSOCIATES • SENIOR RESEARCHERS
SCIENTIFIC PUBLICATIONS • RBI scientists - 6% of the total no. of scientists in Croatia • 32 % of all Croatian articles cited in Current Content CC Papers: 2004 - 2009
How can the best scientific institute in Croatia contribute to development of the TT and National Innovation System?
THERE IS NO EFFICIENT TT and INNOVATION SYSTEM WITHOUT: • Strong basic research • Strong applied research • Strong cooperation between scientific community, academia and industry • Strong education system • Strong leadership • STRONG NATIONAL GOVERNMENT COMMITMENT
INNOVATIONS IPANDPATENTS FUNDING IDEAS TECHNOLOGYTRANSFER
Intellectual Property andCommercialization • RBI’s Agency founded in 2007 • specialized in commercialization of innovationsand • technology transfer • links scienceand technology with economy and industry. Portfolio:more than 80 innovations and scientificprojects in various fields with commercial potentialbut primarily in chemistry, medicine, biology, physics and informatics • 7 employees, • more than 80 projects (32 outsideRBI), • 32 patent applications • 7 licenseagreements, 1 patent granted and 5 spin-offs
Spin off companies • Ruđer Innovations • Commercialization of innovations and technology transfer • Ruđer MedikolCyclotrone • Development and production of radionuclides • Ruđer Medikol Diagnostics • Breast and other genetic hereditary diagnostics • Initium Futuri • Innovative ICT technologies • BioZyne (in formation) • Biotech company for R&D in the life sciences (cancer drugs)
IF IN NUMBERS • Investment: 154kEUR • Ownership: RI 51%, inventors (4) 49% • Profit sharing: RI:51%, inventors (4) 49%
IF PROJECT PORTFOLIO • SmartECG - Mobile Heartwork analysis and alarming system • Vergilius – Navigation for visually impaired • Eduforia – eLearning and collaboration software • ePortfelj – Web 2.0 personal investment portfolio manager • Custom software and consulting services – one big BPR (Business Process Reengineering) project in progress
RMD IN NUMBERS • Investment: 50kEUR • Ownership: RI 50%, Medikol 50% • Profit sharing: RI:80%,Medikol 20%
RBI EU CENTRE OF EXCELLENCE IMPROVERESEARCHINFRASTRUCTURE INCREASE #INTERNATIONAL PROJECTS COOPERATION WITH INDUSTRY IMPROVEINTEGRATION IMPACT PAPERS VISIBILITY INTERNATIONAL COOPERATION EDUCATION PATENTS, FUNDRAISING